Status and phase
Conditions
Treatments
About
This is a prospective multicenter clinical study. This study aims to construct an auxiliary decision-making system for lung cancer immunotherapy combined with radiotherapy by fusing three modes of imagomics, clinicopathological features, and molecular pathological features.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
140 participants in 3 patient groups
Loading...
Central trial contact
Nong C Yang, MD; Yongchang C Zhang, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal